Xylem price target raised to $132 from $131 at Deutsche Bank

Deutsche Bank analyst Andrew Krill raised the firm’s price target on Xylem to $132 from $131 and keeps a Buy rating on the shares. The company’s earnings report “checked all the boxes” with a modest beat, strong orders and achievable guidance, the analyst tells investors in a research note.